Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
04/2004
04/22/2004US20040077056 By culturing a Shingomonas bacteria in a fermentation broth for a time and temperature effective for providing a sphingan exopolysaccharide in a slime form
04/22/2004US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
04/22/2004US20040077047 Allows efficient production of heterologous protein and wherein any contamination of the product protein by vegetative spores is avoided
04/22/2004US20040077046 Histone deacetylase-related gene and protein
04/22/2004US20040077045 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA)
04/22/2004US20040077038 Methods for production of proteins in host cells
04/22/2004US20040077035 Mutated penicillin expandase and process for preparing 7-ADCA using the same
04/22/2004US20040077034 Mutated penicillin expandase and process for preparing 7-ADCA using the same
04/22/2004US20040077029 Human protooncogene and protein encoded therein
04/22/2004US20040077016 The bacteria are good research materials for investigating the interrelation between enzyme structures and functions since they are stable at extreme pH, crystallize easily and are easy- to-handle
04/22/2004US20040077012 Thermostable DNA polymerases that can serve as chromosomal replicases and are derived from thermophilic bacteria
04/22/2004US20040077009 Human cyclin-dependent kinase (hPNQALRE)
04/22/2004US20040077007 Human SMN-like protein
04/22/2004US20040077002 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty; atherosclerosis
04/22/2004US20040077000 Using cynomologous monkey P-glycoprotein nucleic acids and polypeptides in determining bioavailability of drugs and for screening for inhibitors of cynomologous P-glycoprotein
04/22/2004US20040076992 Novel cell adhesion molecule specific to activated leukocyte
04/22/2004US20040076990 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection
04/22/2004US20040076986 A gene and/or a protein involved in the prevention or treatment of allergic diseases and dermatitis
04/22/2004US20040076985 Reagents which regulate human chemokine-like receptor and reagents which bind to human chemokine-like receptor gene products, useful in preventing, ameliorating, or correcting dysfunctions or diseases including HIV infection,
04/22/2004US20040076982 3-hydroxypropionic acid and other organic compounds
04/22/2004US20040076955 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
04/22/2004US20040076951 Also antibodies, gene chips, transgenic non-human animals
04/22/2004US20040076638 Methods for preparing bacillus anthracis protective antigen for use in vaccines
04/22/2004US20040076625 A fusion proteins comprising self or non-self antigens, is used for treatment and prevention of immunoglobulin E related diseases, gene expression
04/22/2004US20040076615 Genetic engineered primers with nucleotide sequences, for treating diarrhea, colitis, intestinal infections, candida infections or skin diseases
04/22/2004US20040076614 For natural cellular immune defense in humans/animals; for foods/feeds
04/22/2004US20040076607 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
04/22/2004DE10247755A1 New fusion polypeptide, useful for treating e.g. cancer, infections and inflammation, comprises binding domain for cell-surface molecule and fragment of tumor necrosis factor ligand
04/22/2004CA2501875A1 Cap-binding protein
04/22/2004CA2501851A1 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
04/22/2004CA2501752A1 Compositions, organisms and methodologies employing a novel human kinase
04/22/2004CA2501574A1 Process for the biological production of 1,3-propanediol with high yield
04/22/2004CA2501445A1 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof
04/22/2004CA2500741A1 Glucose transport mutants for production of biomaterial
04/22/2004CA2500592A1 Compositions, organisms and methodologies employing a novel human kinase
04/22/2004CA2499609A1 Culture method of controlling the composition of copolymer polyester
04/22/2004CA2499607A1 Method of coagulating poly-3-hydroxyalkanoic acid
04/21/2004EP1411126A1 Nitrilase and encoding polynucleotide
04/21/2004EP1411121A1 Dna fragments containing gene having function relating to autonomous proliferation of plasmid
04/21/2004EP1411116A1 PEPTIDE SYNTHASE GENE, PEPTIDE SYNTHASE AND PROCESS FOR PRODUCING DIPEPTIDE
04/21/2004EP1411064A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
04/21/2004EP1411062A1 Process for producing dipeptide,peptide synthase to be used therein and process for producing peptide synthase
04/21/2004EP1411060A1 PROCESS FOR PRODUCING DIPEPTIDE, L−AMINO ACID AMIDE HYDROLASE TO BE USED THEREIN AND PROCESS FOR PRODUCING L−AMINO ACID AMIDE HYDROLASE
04/21/2004EP1410038A2 Assays for identifying modulators of rhomboid polypeptides
04/21/2004EP1409748A2 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins
04/21/2004EP1409738A1 Methods and oligonucleotides for the detection of salmonella sp.,e.coli o157:h7,and listeria monocytogenes
04/21/2004EP1409715A2 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides
04/21/2004EP1409708A2 Glucans and glucansucrases derived from lactic acid bacteria
04/21/2004EP1409703A2 Metabolic controlled fermentation process for pseudomonic acid production
04/21/2004EP1409694A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof
04/21/2004EP1409691A2 Stereoselective preparation of cyclic l-amino acids
04/21/2004EP1409688A2 Nucleic acid sequences encoding enantioselective amidases
04/21/2004EP1409684A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis
04/21/2004EP1409683A2 i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF
04/21/2004EP1409681A2 Proteins and nucleic acids encoding same
04/21/2004EP1409680A2 Novel human proton-gated channels
04/21/2004EP1409677A2 Receptors and membrane-associated proteins
04/21/2004EP1409673A2 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1
04/21/2004EP1409665A2 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production
04/21/2004EP1409661A2 Hdac9 polypeptides and polynucleotides and uses thereof
04/21/2004EP1409660A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
04/21/2004EP1409659A2 Subtilase variants
04/21/2004EP1409658A2 Aggrecanase molecules
04/21/2004EP1409655A2 Immunoglobulin superfamily proteins
04/21/2004EP1409645A1 Probiotic lactobacillus salivarius strains
04/21/2004EP1409644A1 Probiotic bifidobacterium strains
04/21/2004EP1409643A1 Probiotic lactobacillus casei strains
04/21/2004EP1409642A1 Thermophilic microorganism bacillus coagulans strain sim-t dsm 14043 for the production of l(+)-lactate from fermentable sugars and their mixtures
04/21/2004EP1409641A2 Engineering fungi for the utilisation of l-arabinose
04/21/2004EP1409640A1 Adaptation of bacteria for use in leaching
04/21/2004EP1409550A1 Extracellular messengers
04/21/2004EP1409547A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
04/21/2004EP1409545A2 Allelic variants of grp50
04/21/2004EP1409542A2 Blood group antigen fusion polypeptides and methods of use thereof
04/21/2004EP1409535A2 Human secreted proteins
04/21/2004EP1409533A2 Recombinant plasmodium falciparum merozoite protein-1/42 vaccine
04/21/2004EP1409528A2 Novel compounds
04/21/2004EP1409523A2 Pancam nucleic acids and polypeptides
04/21/2004EP1409517A2 Fusion proteins based upon somatostatin receptors
04/21/2004EP1409010A1 Treating endotoxemia and related disorders with probiotics
04/21/2004EP1408909A2 Improved conditionally replicating vectors for inhibiting viral infections
04/21/2004EP1408811A2 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
04/21/2004EP1408808A2 Methods for diagnosing and treating heart disease
04/21/2004EP1408760A2 Consumable product containing probiotics
04/21/2004EP1191707B1 Power amplifier sharing in a wireless communication system with transmit diversity
04/21/2004EP1018341B1 Antistress agents and functional foods
04/21/2004EP0836647B1 Antiviral proteins, dna coding sequences therefor, and uses thereof
04/21/2004CN1491282A Process for producing prenyl alcohol
04/21/2004CN1491281A Neurotonin and use thereof
04/21/2004CN1491280A Synovial membrane cell protein
04/21/2004CN1491278A Lipase variants
04/21/2004CN1491116A Hepatitis B virus treatment
04/21/2004CN1490406A Recombined human organ plasminogen activator streptokinase and its preparation
04/21/2004CN1490398A Bacillus pumilus for killing nematoda and its preparation and use
04/21/2004CN1490397A Preservation of living bacteria in biological products by corn starch
04/21/2004CN1490396A Zytase, its producing method and special bacterial strain for production
04/21/2004CN1490280A Microorganic fertilizer against various bacteria and its preparation and use
04/21/2004CN1490049A CD26/DPP IV application for medicine in preparing treatment and/or diagnostic disease
04/21/2004CN1146664C Fusion polypeptides comprising and IgE-binding domain and HSA component, and their diagnostic and therapeutic uses
04/21/2004CN1146663C Selection marker